Detalhe da pesquisa
1.
Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res
; 21(1): 97, 2019 08 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-31455425
2.
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01).
Breast Cancer Res
; 18(1): 3, 2016 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26738606
3.
Feasibility of online radial magnetic resonance imaging for adaptive radiotherapy of pancreatic tumors.
Phys Imaging Radiat Oncol
; 26: 100434, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37034029
4.
Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac.
Front Oncol
; 13: 1040673, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37854684
5.
Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort.
Int J Radiat Oncol Biol Phys
; 107(1): 39-47, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007565
6.
Improved Circulating Tumor Cell Detection by a Combined EpCAM and MCAM CellSearch Enrichment Approach in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Mol Cancer Ther
; 14(3): 821-7, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25552367
7.
[Antitumour effects of bisphosphonates in breast cancer]. / Antitumoreffect van bisfosfonaten bij mammacarcinoom.
Ned Tijdschr Geneeskd
; 154: A1951, 2010.
Artigo
em Holandês
| MEDLINE | ID: mdl-21083955